Jared Kaltwasser

The study was designed to help scientists better understand how to prevent in-hospital transmission of C difficile.

The study is believed to be the first to examine such a broad array of patient groups.

Competition among species has therapeutic implications, the authors found.

The new guidelines for the first time offer guidance for patients who are not fully adherent to direct-acting antivirals.

Expanding peripartum prophylaxis could be more cost-effective, but would likely lead to significant over-treatment.

Investigators found most cases were infected with adeno-associated virus 2 and a helper virus, though it’s unclear what role the former plays.

Data from New Haven County, Connecticut, suggests the pandemic might have hurt efforts to curb recurrent CDI.

While efforts to curb in-hospital infection seem to have paid off, community-acquired cases appear headed in the opposite direction.

Simulations suggest deaths from COVID-19 could be cut in half if 80% of eligible patients took the antiviral therapy.

The investigators found the risk of hospital-acquired Clostridioides difficile (CDI) infection increased when a hospital switched to serving only coronavirus disease 2019 patients.

Higher poverty, crowding, and lower education levels disproportionately increased a person’s risk of S aureus infection, according to a new study.

The vaccine even provided significant protection when children had just one dose, investigators found.

A new report tracking patients suggests that even those who return to work experience persistent symptoms.

The data may help explain why COVID-19 patients experience dangerous secondary infections.

The study showed, however, that physicians can help solve the problem if they are willing to answer patient’s questions about the therapy’s efficacy and safety.

A new report finds veterans who took vitamin D supplements were less likely to get COVID-19 and less likely to die within 30 days of infection.

As viral hepatitis is the most common blood-transmitted infection globally, assessing the toll of hepatitis and hepatitis-related conditions is critical.

The company says it plans to begin talking with regulators next year after seeing positive efficacy data in the trials.

The closely watched therapeutic candidate led to long-term responses in 90% of patients who benefited from the therapy.

November is Clostridioides difficile (C diff) awareness month. The Peggy Lillis Foundation hopes to use the month to increase the public’s awareness of the dangers of the infection.

Over the past decade, the number of cases of hepatitis A infection at a Turkish hospital has decreased, but a growing proportion of cases come from migrants to the country.

A new review article suggests it is possible to eradicate hepatitis C virus infections among people with hemophilia, but it will take intense focus from public health agencies.

Interim data show a bivalent vaccine that contains the Omicron variant may be more effective.

There are a number of programs designed to help lower rates of infection and transmission amongst this industry's workforce in South Africa.

When physicians were told that a case was likely viral they were less likely to prescribe antibiotics, a new study shows.

A new report underscores a persistent problem of patients not receiving antivirals despite their high curative rate.

People who initially received an mRNA vaccine but were boosted with the Janssen vaccine had superior immune responses, the study found.

The study was longitudinal in nature, comparing at-risk people who became infected with HIV to at-risk people who did not.

The model suggests screening unvaccinated students could reduce absences by 80% compared to reactively closing classes with infected students.

Though all racial and ethnic groups saw declines in life expectancy, the impact was greater among members of minority groups.